INSMED INC (INSM) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
INSMED INC cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from exercise of stock options and ESPP → financing reconciliation: $58,319,000.00financing reconciliation → Net cash from financing activities: $56,693,000.00financing reconciliation → Payments of finance lease principal: $1,626,000.00Maturities of marketable securities → investing reconciliation: $714,000,000.00investing reconciliation → Net cash from investing activities: $290,033,000.00investing reconciliation → Purchase of marketable securities: $399,228,000.00investing reconciliation → Payment of AZ milestone: $15,000,000.00investing reconciliation → Purchase of fixed assets: $9,739,000.00Net cash used in operating activities → operating reconciliation: $311,566,000.00Stock-based compensation expense → operating reconciliation: $87,008,000.00Accounts payable and accrued liabilities → operating reconciliation: $34,945,000.00Royalty financing non-cash interest expense → operating reconciliation: $10,243,000.00Depreciation → operating reconciliation: $6,113,000.00Amortization of intangible assets → operating reconciliation: $4,162,000.00Amortization of debt issuance costs → operating reconciliation: $2,811,000.00Non-cash operating lease expense → operating reconciliation: $1,386,000.00Finance lease amortization expense → operating reconciliation: $1,356,000.00operating reconciliation → Net loss: $176,805,000.00operating reconciliation → Change in fair value of contingent consideration: $146,721,000.00operating reconciliation → Accounts receivable: $75,350,000.00operating reconciliation → Prepaid expenses and other current assets: $25,049,000.00operating reconciliation → Inventory: $14,860,000.00operating reconciliation → Accretion of discount on marketable securities, net: $11,977,000.00operating reconciliation → Other assets: $7,587,000.00operating reconciliation → Other liabilities: $1,241,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $510,445,000.00Net cash from financing activities → Cash sources and uses: $56,693,000.00Net cash from investing activities → Cash sources and uses: $290,033,000.00Cash sources and uses → Exchange-rate effect: $840,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $544,765,000.00Cash sources and uses → Net cash used in operating activities: $311,566,000.00Net loss: -$176,805,000.00Net loss−$176.81 MFinance lease amortization expense: $1,356,000.00Finance lease asset amortization+$1.36 MAmortization of debt issuance costs: $2,811,000.00Debt cost amortization+$2.81 MAccretion of discount on marketable securities, net: -$11,977,000.00Securities accretion, net−$11.98 MAmortization of intangible assets: $4,162,000.00Intangible amortization+$4.16 MChange in fair value of contingent consideration: -$146,721,000.00Contingent consideration change−$146.72 MStock-based compensation expense: $87,008,000.00Stock-based compensation+$87.01 MInventory: -$14,860,000.00Inventories−$14.86 MAccounts receivable: -$75,350,000.00Accounts receivable−$75.35 MOther liabilities: -$1,241,000.00Other operating liabilities−$1.24 MAccounts payable and accrued liabilities: $34,945,000.00Payables & accrued liabilities+$34.95 MDepreciation: $6,113,000.00Depreciation expense+$6.11 MPrepaid expenses and other current assets: -$25,049,000.00Prepaid & other assets−$25.05 MRoyalty financing non-cash interest expense: $10,243,000.00Other non-cash expenses+$10.24 MNon-cash operating lease expense: $1,386,000.00Non-cash operating lease expense+$1.39 MOther assets: -$7,587,000.00Other noncurrent assets−$7.59 MNet cash used in operating activities: -$311,566,000.00. Cash required to fund net payments.Operating cash−$311.57 Moperating reconciliation: $459,590,000.00Proceeds from exercise of stock options and ESPP: $58,319,000.00Stock option exercises+$58.32 MProceeds from issuance of common stock, net: $0.00Payments of principal of 0.75% convertible senior notes due 2028: $0.00Payments of finance lease principal: -$1,626,000.00Finance lease payments−$1.63 MNet cash from financing activities: $56,693,000.00Financing cash+$56.69 Mfinancing reconciliation: $58,319,000.00Purchase of fixed assets: -$9,739,000.00PP&E purchases−$9.74 MMaturities of marketable securities: $714,000,000.00Marketable securities proceeds+$714.00 MPurchase of marketable securities: -$399,228,000.00Marketable securities purchases−$399.23 MPayment of AZ milestone: -$15,000,000.00Payment of AZ milestone−$15.00 MNet cash from investing activities: $290,033,000.00Investing cash+$290.03 Minvesting reconciliation: $714,000,000.00Cash sources and uses: $857,171,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $510,445,000.00Beginning cash$510.45 MEnding cash: Cash, cash equivalents, and restricted cash: $544,765,000.00Ending cash$544.77 MExchange-rate effect: -$840,000.00FX effect−$840.00 KCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsNet loss −$176.81M − net operating adjustments $134.76M = operating cash −$311.57MFree cash flow−$321.31 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$34.32 MEnding cash − beginning cash
Chart details

INSMED INC cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
510,445,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 311,566,000 US dollars. Net cash used.
Net loss
negative 176,805,000 US dollars
Finance lease amortization expense
1,356,000 US dollars
Amortization of debt issuance costs
2,811,000 US dollars
Accretion of discount on marketable securities, net
negative 11,977,000 US dollars
Amortization of intangible assets
4,162,000 US dollars
Change in fair value of contingent consideration
negative 146,721,000 US dollars
Stock-based compensation expense
87,008,000 US dollars
Inventory
negative 14,860,000 US dollars
Accounts receivable
negative 75,350,000 US dollars
Other liabilities
negative 1,241,000 US dollars
Accounts payable and accrued liabilities
34,945,000 US dollars
Depreciation
6,113,000 US dollars
Prepaid expenses and other current assets
negative 25,049,000 US dollars
Royalty financing non-cash interest expense
10,243,000 US dollars
Non-cash operating lease expense
1,386,000 US dollars
Other assets
negative 7,587,000 US dollars
Investing activities
290,033,000 US dollars. Net cash provided.
Purchase of fixed assets
negative 9,739,000 US dollars
Maturities of marketable securities
714,000,000 US dollars
Purchase of marketable securities
negative 399,228,000 US dollars
Payment of AZ milestone
negative 15,000,000 US dollars
Financing activities
56,693,000 US dollars. Net cash provided.
Proceeds from exercise of stock options and ESPP
58,319,000 US dollars
Proceeds from issuance of common stock, net
0 US dollars
Payments of principal of 0.75% convertible senior notes due 2028
0 US dollars
Payments of finance lease principal
negative 1,626,000 US dollars
Operating adjustment reconciliation
459,590,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
58,319,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
714,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 840,000 US dollars
Ending cash on Jun 30, 2026
544,765,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
857,171,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
34,320,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
negative 311,566,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
9,739,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 321,305,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$176.81M − net operating adjustments $134.76M = operating cash −$311.57M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 311,566,000 US dollars minus 9,739,000 US dollars equals negative 321,305,000 US dollars.
INSMED INC (INSM) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!